The challenges of the new Annex 1 to the PM of the Pharmaceutical Industry
The pharmaceutical sector is highly regulated and only ‘zero risk’ is allowed; in this context, ANNEX1 is the bible.
Zero risk’ also comes through the design of the pharmaceutical infrastructure, and through IQ-OQ-PQ and Area Validation it is realised in the drug.
PNRR: The DNSH principle verification activities
At Planex, we can support you in assessing and managing the damage a measure may cause, so that your intervention can access NRP funds.